Home › Funds › Trexquant Investment LP › MRNA

Trexquant Investment LP position in MRNA

MODERNA INC · Health Care

Trexquant Investment LP reported holding 505,160 shares of MRNA (MODERNA INC) in its Q2 2026 13F filing — a position valued at US$35.4M, representing 0.33% of its reported portfolio and ranking #26 among its reported holdings. Trexquant Investment LP has disclosed MRNA holdings in 6 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)505.16K sh
Reported value held$35.38M
Portfolio Weight0.33%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Trexquant Investment LP's MRNA position evolved

Trexquant Investment LP first disclosed a stake in MRNA in Q3 2023 at 69,724 shares (US$7.2M). The position peaked in Q2 2026 at 505,160 shares, worth US$35.4M. Across 6 filings, Trexquant Investment LP increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 505,160 shares valued at US$35.4M — an increase of 21,189 shares quarter over quarter.. Notable position changes include a 91% increase in Q3 2025 (shares rose 14% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 69.72K $7.20M New
Q2 2024 89.18K $10.59M New
Q2 2025 157.33K $4.34M New
Q3 2025 299.94K $7.75M Add
Q1 2026 483.97K $24.59M New
Q2 2026 505.16K $35.38M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MRNA and 13F data

MRNA (MODERNA INC) is a Health Care company. 37 other funds we track also report a position in MRNA — the largest reported positions include Baillie Gifford & Co (US$1.28B), Theleme Partners LLP (US$564.3M), BANQUE PICTET & CIE SA (US$414.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MRNA

All MRNA fund holders →

FAQ

How long has Trexquant Investment LP held MRNA?

Trexquant Investment LP has disclosed MRNA holdings in 6 of the last 12 reported quarters, going back to Q3 2023.

What is Trexquant Investment LP's current position in MRNA?

As of Q2 2026, Trexquant Investment LP holds 505.16K shares of MRNA (MODERNA INC), valued at $35.38M, representing 0.33% of its reported portfolio and ranking #26.

Has Trexquant Investment LP been buying or selling MRNA?

In the latest 13F filing (Q2 2026), Trexquant Investment LP increased its position in MRNA. The position peaked in Q2 2026 at 505.16K shares.

Which other funds hold MRNA?

Other major institutional holders of MRNA include Baillie Gifford & Co, Theleme Partners LLP, BANQUE PICTET & CIE SA, among 37 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.